Recently, the American Joint Committee on Cancer (AJCC), in conjunction with the International Union Against Cancer, released an update of their TNM staging for cervical cancer (version 9). Not only does the new version allow for better alignment with the International Federation of Obstetrics and Gynecology (FIGO) system, but there are also important changes that serve to better allow for integration of parameters that clinicians need for management planning and prognosis. These changes are herein outlined in this concise commentary.